Evidence map›Paper›PMID 39795934›Full record

ArticleInternational journal of molecular sciences2024

Can α-Mangostin and Photodynamic Therapy Support Ciprofloxacin in the Inactivation of Uropathogenic

Dorota Wojnicz, Kamila Korzekwa, Mateusz Guźniczak, Maciej Wernecki, Agnieszka Ulatowska-Jarża, Igor Buzalewicz, Dorota Tichaczek-Goska

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Determinants of Antibacterial Activity inInternational journal of molecular sciences · 2026
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Dorota WojniczDepartment of Biology and Medical Parasitology, Faculty of Medicine, Wrocław Medical University, Mikulicza-Radeckiego 9, 50-345 Wroclaw, Poland.ORCID 0000-0003-1972-1548
Kamila KorzekwaDepartment of Microbiology, Faculty of Biological Sciences, University of Wrocław, Przybyszewskiego 63, 51-148 Wroclaw, Poland.ORCID 0000-0002-2792-8752
Mateusz GuźniczakBioQuanty Group, Department of Biomedical Engineering, Faculty of Fundamental Problems of Technology, Wroclaw University of Science and Technology, 27 Wybrzeże S. Wyspiańskiego St., 50-370 Wroclaw, Poland.ORCID 0009-0001-0570-8767
Maciej WerneckiDepartment of Microbiology, Faculty of Biological Sciences, University of Wrocław, Przybyszewskiego 63, 51-148 Wroclaw, Poland.ORCID 0000-0003-4821-5898
Agnieszka Ulatowska-JarżaBioQuanty Group, Department of Biomedical Engineering, Faculty of Fundamental Problems of Technology, Wroclaw University of Science and Technology, 27 Wybrzeże S. Wyspiańskiego St., 50-370 Wroclaw, Poland.ORCID 0000-0003-2690-7885
Igor BuzalewiczBioQuanty Group, Department of Biomedical Engineering, Faculty of Fundamental Problems of Technology, Wroclaw University of Science and Technology, 27 Wybrzeże S. Wyspiańskiego St., 50-370 Wroclaw, Poland.ORCID 0000-0002-9774-4625
Dorota Tichaczek-GoskaDepartment of Biology and Medical Parasitology, Faculty of Medicine, Wrocław Medical University, Mikulicza-Radeckiego 9, 50-345 Wroclaw, Poland.ORCID 0000-0002-8540-0876

Funding

Wroclaw Medical University SUBK.A060.24.052 and SUBZ.A060.23.065
6 · The paper itself

Abstract

Multidrug-resistant bacteria represent a significant challenge in the treatment of bacterial infections, often leading to therapeutic failures. This issue underlines the need to develop strategies that improve the efficacy of conventional antibiotic therapies. In this study, we aimed to assess whether a plant-derived compound, α-mangostin, and photodynamic therapy (PDT) could enhance the antibacterial activity of ciprofloxacin against uropathogenic strains of

Indexed as

Anti-Bacterial AgentsCiprofloxacinPhotochemotherapyStaphylococcus aureusUropathogenic Escherichia coliXanthonesDrug Resistance, Multiple, BacterialDrug SynergismEscherichia coli InfectionsHumansMicrobial Sensitivity TestsPhotosensitizing AgentsAnti-Bacterial AgentsCiprofloxacinmangostinPhotosensitizing AgentsXanthonesciprofloxacinmultidrug-resistant bacteriaPDTUTIα-mangostin

Identifiers

PMID39795934
PMCPMC11720700

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.